Dr. Annalisa Na, PT, PhD
Claim this profileStudies Chronic Pain
Studies Follicular Lymphoma
1 reported clinical trial
1 drug studied
More about Annalisa Na, PT, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Annalisa Na, PT, PhD has experience with
- Tailored Physical Activity Program
Breakdown of trials Annalisa Na, PT, PhD has run
Follicular Lymphoma
Cognitive Impairment
Limited Mobility
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Annalisa Na, PT, PhD specialize in?
Annalisa Na, PT, PhD focuses on Chronic Pain and Follicular Lymphoma. In particular, much of their work with Chronic Pain has involved treating patients, or patients who are undergoing treatment.
Is Annalisa Na, PT, PhD currently recruiting for clinical trials?
No, Annalisa Na, PT, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Annalisa Na, PT, PhD has studied deeply?
Yes, Annalisa Na, PT, PhD has studied treatments such as Tailored Physical Activity Program.
What is the best way to schedule an appointment with Annalisa Na, PT, PhD?
Apply for one of the trials that Annalisa Na, PT, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.